Overview
Michio Hirano is a Neurologist in New York, New York. Dr. Hirano is highly rated in 33 conditions, according to our data. His top areas of expertise are Mitochondrial Neurogastrointestinal Encephalopathy Disease, MELAS Syndrome, Progressive External Ophthalmoplegia, and Acute Cerebellar Ataxia. Dr. Hirano is currently accepting new patients.
His clinical research consists of co-authoring 178 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- POS
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
710 W 168th St, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Werner K Doyle M.D. PC
Orrin Devinsky is a Neurologist in New York, New York. Dr. Devinsky is highly rated in 31 conditions, according to our data. His top areas of expertise are Myoclonic Epilepsy, Dravet Syndrome, Seizures, Epilepsy, and Deep Brain Stimulation.
CUIMC/Neurological Institute Of New York
Andrew B. Lassman, MD, FAAN, FASCO, is a Professor of Neurology and Associate Dean of Clinical Research Compliance at the Columbia University Vagelos College of Physicians and Surgeons. Dr. Lassman also serves as Chief of the Division of Neuro-Oncology and Vice Chair for Clinical Research in the Department of Neurology, and as Associate Director for Clinical Trials at the Herbert Irving Comprehensive Cancer Center. As a clinician-scientist, Dr. Lassman focuses both his research and clinical efforts on improving the understanding and treatment of brain tumors.Dr. Lassman has particular expertise in translational clinical trials for brain tumors, with molecular correlative analyses to understand the reasons for treatment success or failure, and to refine treatment paradigms. Dr. Lassman has led retrospective studies, single institution prospective clinical trials, and multicenter prospective trials conducted nationally through the National Cancer Institute sponsored National Clinical Trials Network. His contributions to the field of Neuro-Oncology have been recognized with numerous awards, including the Preuss Award in Neuro-Oncology from the American Academy of Neurology, the Boyer Clinical Research Award from Memorial Sloan-Kettering Cancer Center, and the Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer.Dr. Lassman earned his BS and MS degrees in Molecular Biophysics and Biochemistry, as part of a combined four-year program at Yale University. He attained his MD from Columbia University College of Physicians and Surgeons and completed Neurology residency at the Neurological Institute of New York, at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman completed his fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center, where he joined the faculty and served as fellowship director, until his return to NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman is highly rated in 15 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.
Dysautonomia Center LLP
Horacio Kaufmann is a Neurologist in New York, New York. Dr. Kaufmann is highly rated in 13 conditions, according to our data. His top areas of expertise are Familial Dysautonomia, Hajdu-Cheney Syndrome, Hereditary Sensory and Autonomic Neuropathy Type 2, and Orthostatic Hypotension.
Frequently Asked Questions about Dr. Michio Hirano
How do I make an appointment with Dr. Michio Hirano?
You can book an appointment with Dr. Michio Hirano by calling their office at 914-495-2019. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michio Hirano a top-rated expert for Mitochondrial Neurogastrointestinal Encephalopathy Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michio Hirano is classified as an Elite expert for Mitochondrial Neurogastrointestinal Encephalopathy Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michio Hirano specialize in?
While Dr. Michio Hirano is a Neurology, they have specific expertise in Mitochondrial Neurogastrointestinal Encephalopathy Disease, MELAS Syndrome, and Progressive External Ophthalmoplegia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.
Does Dr. Michio Hirano participate in research or clinical trials?
Yes. Dr. Michio Hirano has published 178 articles and abstracts on conditions like Mitochondrial Neurogastrointestinal Encephalopathy Disease. You can view a list of Dr. Michio Hirano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michio Hirano accept my insurance?
Dr. Michio Hirano accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 914-495-2019 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MELAS SyndromeDr. Hirano isElite. Learn about MELAS Syndrome.
- Mitochondrial Neurogastrointestinal Encephalopathy Disease
- Progressive External Ophthalmoplegia
- Distinguished
- Acute Cerebellar AtaxiaDr. Hirano isDistinguished. Learn about Acute Cerebellar Ataxia.
- Leigh SyndromeDr. Hirano isDistinguished. Learn about Leigh Syndrome.
- Oculopharyngeal Muscular DystrophyDr. Hirano isDistinguished. Learn about Oculopharyngeal Muscular Dystrophy.
- Sensorimotor PolyneuropathyDr. Hirano isDistinguished. Learn about Sensorimotor Polyneuropathy.
- X-Linked Dominant Scapuloperoneal MyopathyDr. Hirano isDistinguished. Learn about X-Linked Dominant Scapuloperoneal Myopathy.
- Advanced
- Adult Polyglucosan Body DiseaseDr. Hirano isAdvanced. Learn about Adult Polyglucosan Body Disease.
- Andersen DiseaseDr. Hirano isAdvanced. Learn about Andersen Disease.
- Benign Autosomal Dominant Myopathy
- Brown SyndromeDr. Hirano isAdvanced. Learn about Brown Syndrome.
- Central Core DiseaseDr. Hirano isAdvanced. Learn about Central Core Disease.
- Centronuclear MyopathyDr. Hirano isAdvanced. Learn about Centronuclear Myopathy.
- Experienced
- Alpers-Huttenlocher SyndromeDr. Hirano isExperienced. Learn about Alpers-Huttenlocher Syndrome.
- AminoaciduriaDr. Hirano isExperienced. Learn about Aminoaciduria.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Becker Muscular DystrophyDr. Hirano isExperienced. Learn about Becker Muscular Dystrophy.
- CACH SyndromeDr. Hirano isExperienced. Learn about CACH Syndrome.
- Coenzyme Q Cytochrome C Reductase Deficiency
